Loading clinical trials...
Loading clinical trials...
The aim of this study was to evaluate the effects of dexmedetomidine on renal function, hormonal and hemodynamic parameters in contrast media induced diabetic patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
TC Erciyes University
NCT01866800 · Radiographic Contrast Agent Nephropathy, Aortic Valve Stenosis With Insufficiency
NCT01654328 · Radiographic Contrast Agent Nephropathy
NCT00584350 · Radiographic Contrast Agent Nephropathy, Renal Failure, and more
NCT01820195 · Chronic Kidney Disease Stage 2, Radiographic Contrast Agent Nephropathy
NCT01778140 · Radiographic Contrast Agent Nephropathy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions